NeoGenomics Laboratories, Inc. vs its peers
The 10 largest Health Care Services companies by market value, prices of Nov 20, 2026
NeoGenomics Laboratories, Inc. is the 10th largest of the 10 biggest Health Care Services companies on OQRO by market value, at $1.92B. Its revenue of $727M in fiscal 2025 ranks 10th of 10. It runs at an operating loss of 16% of revenue, against a group median margin of 7%. Revenue grew 10% on the year before, against a median of +11.3%.
Side by side
| Company | Market value | Revenue | Growth y/y | 5-yr growth / yr | Gross margin | Operating margin | Net margin | Free cash flow margin | R&D / revenue | Price / earnings | Price / sales | FCF yield | Stock, 12 months |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CignaCI · FY2025 | $71.4B | $275B | +11.2% | +11.4% | 21.8% | 3.3% | 2.2% | — | — | 12.0x | 0.3x | — |
Each company’s latest fiscal year (FY), so the years can end a few months apart. Price ratios divide today’s market value by that year’s figure; price / earnings is left out on a loss. “—” means the company did not tag that line in its annual report.
Operating margin
- CON15%
- DVA15%
- DGX14%
- CHE13%
- LH10%
- CI3%
- RDNT3%
- BTSG2%
- LFST2%
Compare NeoGenomics Laboratories, Inc. head to head
Where NeoGenomics Laboratories, Inc.’s revenue comes from and where it goes: NeoGenomics Laboratories, Inc. revenue breakdown. Twenty years of results: NeoGenomics Laboratories, Inc. financial history.
Common questions
Who are NeoGenomics Laboratories, Inc.'s competitors?
The largest companies in its industry (Health Care Services) by market value: Cigna (CI), Labcorp (LH), Quest Diagnostics (DGX), BrightSpring Health Services (BTSG), DaVita (DVA), Chemed Corp. (CHE), RadNet, Inc. (RDNT), Concentra Group Holdings Parent, Inc. (CON) and Lifestance Health (LFST). They share NeoGenomics Laboratories, Inc.'s industry listing; not every one competes with it on every product.
Is NeoGenomics Laboratories, Inc. bigger than Cigna?
No, by market value: NeoGenomics Laboratories, Inc. is worth $1.92B and Cigna $71.4B. By revenue, NeoGenomics Laboratories, Inc. brought in $727M in fiscal 2025 and Cigna $275B in fiscal 2025.
Where these figures come from
The group is the companies OQRO lists in the same industry as NeoGenomics Laboratories, Inc. (Health Care Services), the largest 9 by market value, plus NeoGenomics Laboratories, Inc.. Companies whose latest annual report is more than a year and a half old, or that report in a currency other than the dollar, are left out.
Revenue, operating income, net income, gross profit, research and development and free cash flow (cash from operations minus capital expenditure) are each company’s own full-year lines from its latest 10-K, as tagged in XBRL (SEC companyfacts). Market value is the last close times the shares outstanding on the latest filing. Price / earnings is market value over net income; price / sales is market value over revenue; free cash flow yield is free cash flow over market value. Five-year growth is the yearly rate that takes revenue from five fiscal years before to the latest. This page describes the past and is not investment advice. No language model wrote it.






